CBD Company Trait Biosciences Completes CA$31M Series A Round Led By Btomorrow Ventures

CBD company Trait Biosciences Inc. reported Wednesday it has raised CA$31 million ($25.46 million) through a Series A financing round led by the corporate venturing unit of British American Tobacco, Btomorrow Ventures, and backed by Gotham Green Partners.

Other investors who participated in the round consisted of the company’s previous backers in earlier fundraising rounds.

The Vancouver BC-based company noted that the money raised will be used to support its research and development activities in relation to the commercialization of Trait’s proprietary 2XGLY Water Soluble Cannabinoid .

Research-oriented CBD Trait also plans to use the new …

Full story available on Benzinga.com

More CBD Company Trait Biosciences Completes CA$31M Series A Round Led By Btomorrow Ventures